Somerset Pharma is introducing calcium gluconate 100 mg/ml in two sizes, 50 ml and 100 ml.
The company is the first to launch generic calcium gluconate 100 mg/mL in 50 mL vials. This product approval also received the FDA's Competitive Generic Therapy designation with 180-day exclusivity.
[Read more: Challenges continue, but generics companies see a bright future with biosimilars]
"We take our role as a partner to healthcare professionals very seriously, and one of the ways in which we can contribute to their efforts is by constantly enhancing and evolving our product portfolio to cater to patient needs," said Veerappan Subramanian, chairman and CEO at Somerset Pharma. "We are delighted to be able to contribute once again to this effort, with the launch of Calcium Gluconate Injection, which is also Somerset’s first large volume injectable offering."
[Read more: Senate committee moves FDA User Fee bill with 5 NACDS-backed provisions]